|
Greetings from the NIMH Division of Translational Research (DTR). We are glad to bring you timely news about job announcements, funding opportunities, workshops, and program updates of interest to our translational research community.
In this issue:
The NIMH Division of Translational Research (DTR) is recruiting a program officer for its Translational Genomics for Mental Health (TGMH) program. Individuals who can initiate, plan, develop, and direct NIMH extramural research programs administered by the TGMH Program are encouraged to apply. The selected candidate will serve as Program Officer for a portfolio of grants, contracts, and/or cooperative agreements and participate in collaborative activities with other NIH institutes and federal departments or agencies.
Competitive candidates are expected to be accomplished scientists with a solid grasp of how biomedical research is performed. Specialized knowledge in the field of genomics is essential.
The DTR TGMH program engages in evaluating genomics research ideas in the mental health field that have the potential to advance translational research. Genomics approaches and methods include a broad range from molecular genetics, statistical genetics, transcriptional regulation, and multi-dimensional approaches to phenotypic characterization of mental health populations.
A publication record, prior research experience, and evidence of familiarity with current literature in translational genomics are essential. This position requires the ability to work independently and collaboratively and offers opportunities to impact priorities, develop new initiatives, and contribute to the advancement of a national research program.
A global Health Scientist Administrator announcement will be available through www.usajobs.gov in May 2024; candidates must apply through USAJOBS. Interested applicants are strongly encouraged to also send a letter of interest and curriculum vitae to NIMHsearch@mail.nih.gov. Learn more about the position on the NIMH Careers website.
Please contact Doug Meinecke, Ph.D. with any additional questions about the position.
The NIMH Division of Translational Research is recruiting a program officer to guide research training programs relating to adult psychopathology for its Office of Research Training and Career Development (ORTCD). ORTCD fosters the training of new investigators and enhances the career development of translational scientists through individual fellowship, career development, research education, and institutional research training grants.
The Program Officer will serve as a program expert for the research education and training of individuals in the areas of adult psychopathology related translational research. The Program Officer will provide scientific and programmatic guidance and support to investigators in the early stages of their research careers who are conducting research in fields relevant to the advancement of DTR’s research mission.
Responsibilities include administering and managing an extramural portfolio of research training, education, and career development awards and developing new funding opportunities. The Program Officer will also interact with researchers in the scientific community and with program officers at NIMH, the National Institutes of Health (NIH), and other federal agencies, as appropriate.
A global Health Scientist Administrator announcement will be available through www.usajobs.gov opening May 13, 2024 and closing May 22, 2024. Candidates must apply through USAJOBS. Interested applicants are strongly encouraged to also send a letter of interest and curriculum vitae to NIMHsearch@mail.nih.gov. Learn more about the position on the NIMH Careers website.
Please contact Anita Bechtholt, Ph.D. with any additional questions about the position.
The National Institute of Mental Health is planning a virtual workshop on The Placebo Effect: Key Questions for Translational Research to be held July 11-12, 2024 from 12:00 – 4:00 p.m. ET. The purpose of this virtual workshop is to bring together experts in neurobiology, clinical intervention trials, and regulatory science to examine placebo effects in drug, brain stimulation, and psychosocial interventions for psychiatric indications.
Agenda topics are likely to include discussion of approaches to manage and mitigate the placebo response in clinical trials, disambiguation of signals from clinical trials to potentially isolate active treatment from placebo effects, and psychosocial implications of placebo response.
The full agenda and online registration information will be available soon. The workshop will be open to the scientific community and the public.
For more information on this workshop, please contact Doug Meinecke, Ph.D. or Erin King, Ph.D.
In recognition of National Mental Health Awareness Month in May, the National Institute of Mental Health (NIMH) hosted a Facebook Live event on brain stimulation therapies. The event, held on May 1, featured NIMH expert Sarah H. Lisanby, M.D., Director of the Noninvasive Neuromodulation Unit in the Experimental Therapeutics and Pathophysiology Branch and Director of the NIMH Division of Translational Research.
During the event, Dr. Lisanby described common types of brain stimulation therapies and why they are used, dispels misconceptions, and highlights NIMH-supported research in this area.
A recording and transcript of the event are now available on the NIMH Website.
NIMH recently announced a Request for Information (RFI): Moving beyond Individual-Level Determinants of Mental Health to Address Mental Health Disparities (NOT-MH-24-225). This RFI invites input on addressing gaps in:
- Identifying determinants of mental health disparities beyond the individual level, including, but not limited to, social determinants of health (SDOH) at the social, systemic and structural levels, and
- Developing culturally responsive, multilevel interventions to address mental health disparities.
This RFI seeks input about these research gaps within U.S.-based research from healthcare providers, scientific research communities, patient advocacy groups, people with lived experience, educators, and other interested parties.
Please review the RFI for additional information and further details, including on specific areas of interest. Responses must be received by May 30, 2024.
Please direct all inquiries to Juliette C. McClendon, Ph.D.
For more NIMH and cross-NIH funding opportunities, visit NIMH Opportunities & Announcements.
- Mood and Psychosis Symptoms during the Menopause Transition (Clinical Trial Optional) PAR-23-102 (R21)/PAR-23-097 (R01)
- Neuromodulation/Neurostimulation Device Development for Mental Health Applications (Clinical Trial Not Allowed) PAR-22-038 (R21)/PAR-22-039 (R01)
- Precision Mental Health: Develop Tools to Inform Treatment Selection in Depression (UG3/UH3 Clinical Trial Optional) RFA-MH-25-190
- Utilizing Invasive Recording and Stimulating Opportunities in Humans to Advance Neural Circuitry Understanding of Mental Health Disorders (Clinical Trial Optional) PAR-23-101 (R21)/PAR-23-093 (R01)
|
